Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.42 USD | +1.09% | -10.68% | +171.48% |
Evolution of the average Target Price on Jasper Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Jasper Therapeutics, Inc.
HC Wainwright | |
Evercore ISI | |
RBC Capital Markets | |
TD Cowen | |
Capital One Securities | |
EF Hutton | |
Credit Suisse | |
Oppenheimer | |
Cantor Fitzgerald | |
William Blair & Co. | |
BMO Capital |
EPS Revisions
- Stock Market
- Equities
- JSPR Stock
- Consensus Jasper Therapeutics, Inc.